Exploring the molecular mechanism of dexmedetomidine in alleviating blood-brain barrier disruption in rats with cerebral ischemia reperfusion injury based on network pharmacology.
Overview
- Department of Human Anatomy, Baotou Medical College, Baotou, China
- Department of Anesthesiology, The Third Hospital of Baogang Group, Baotou, China
- Key Laboratory of Human Anatomy, Education Department of Inner Mongolia Autonomous Region, Baotou, China
Abstract
Objective: This study aimed to clarify the neuroprotective effect of dexmedetomidine (DEX) against cerebral ischemia reperfusion injury (CIRI) and its underlying mechanism using network pharmacology and in vivo validation.
Methods: Network pharmacology was employed to explore the mechanism underlying DEX-mediated alleviation of CIRI. A rat CIRI model was established using the suture-occlusion method. Neurological scoring and behavioral assessments were conducted to evaluate neurological and motor functions; histological examination was performed to observe brain tissue and blood–brain barrier (BBB) injury. Western blotting and immunofluorescence analysis were utilized to assess the protein levels of factors associated with BBB integrity.
Results: Network pharmacology analysis revealed that DEX may exert a protective effect against CIRI through the AMPK/
Conclusion: DEX exerts a significant protective effect against BBB injury in rats with CIRI. This neuroprotective effect is mediated by multiple synergistic mechanisms, including the upregulation of tight junction proteins and the regulation of the AMPK/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- doi:10.5061/
dryad.q83bk3jxz , at Dryad; found in “Data availability statement”
Data availability statement
The original contributions presented in the study are publicly available. This data can be found here: https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 4 authors, 6 keywords, 38 references.
Cite
This paper
Lv, X., Gao, W., Zhang, Z.-G., & Jia, J.-X. (2026). Exploring the molecular mechanism of dexmedetomidine in alleviating blood-brain barrier disruption in rats with cerebral ischemia reperfusion injury based on network pharmacology. Frontiers in molecular neuroscience, 19, 1750882. https://
BibTeX
@article{lv2026exploring
author = {Lv, Xue and Gao, Wei and Zhang, Zhi-Guo and Jia, Jian-Xin},
title = {{Exploring the molecular mechanism of dexmedetomidine in alleviating blood-brain barrier disruption in rats with cerebral ischemia reperfusion injury based on network pharmacology}},
journal = {Frontiers in molecular neuroscience},
year = {2026},
month = apr,
volume = {19},
pages = {1750882},
publisher = {Frontiers Media SA},
issn = {1662-5099},
doi = {10.3389/
url = {https://
pmid = {42027298},
pmcid = {PMC13099826}
}
RIS
TY - JOUR
AU - Lv, Xue
AU - Gao, Wei
AU - Zhang, Zhi-Guo
AU - Jia, Jian-Xin
TI - Exploring the molecular mechanism of dexmedetomidine in alleviating blood-brain barrier disruption in rats with cerebral ischemia reperfusion injury based on network pharmacology
T2 - Frontiers in molecular neuroscience
J2 - Front Mol Neurosci
PY - 2026
DA - 2026/
VL - 19
SP - 1750882
SN - 1662-5099
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Exploring the molecular mechanism of dexmedetomidine in alleviating blood-brain barrier disruption in rats with cerebral ischemia reperfusion injury based on network pharmacology",
"container-title": "Frontiers in molecular neuroscience",
"author": [
{
"family": "Lv",
"given": "Xue"
},
{
"family": "Gao",
"given": "Wei"
},
{
"family": "Zhang",
"given": "Zhi-Guo"
},
{
"family": "Jia",
"given": "Jian-Xin"
}
],
"container-title-short":
"volume": "19",
"page": "1750882",
"DOI": "10.3389/
"PMID": "42027298",
"PMCID": "PMC13099826",
"ISSN": "1662-5099",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
8
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.2147/dddt.s479881
- Guanxinning Tablet Alleviates Post-Ischemic Stroke Injury Via Regulating Complement and Coagulation Cascades Pathway and Inflammatory Network Mobilization.Journal: Drug design, development and therapyIn common: stroke, cellular / molecular, 1 reference
- [2] doi:10.2147/nss.s582222
- Network Pharmacology-Based Elucidation of Gu's Anshen Decoction in Modulating TNF Signaling to Ameliorate Insomnia.Journal: Nature and science of sleepIn common: rat, cellular / molecular, 1 reference
- [3] doi:10.7554/elife.107938
- Single-cell transcriptome sequencing for opening the blood-brain barrier through specific mode electroacupuncture stimulation.Journal: eLifeIn common: rat, cellular / molecular, 1 reference
- [4] doi:10.1371/journal.pbio.3003608 [code]
- Ischemic stroke triggers brain-wide synaptic remodeling within four hours.Journal: PLoS biologyIn common: stroke, rat, cellular / molecular, 1 reference
- [5] doi:10.1002/brb3.70850
- KLF7 Blocks MKNK2/
HIF-1 Pathway-Mediated M1 Microglia Polarization to Ameliorate Ischemic Stroke-Induced Neurological Injury. Journal: Brain and behaviorIn common: stroke, rat, cellular / molecular, 1 reference - [6] doi:10.1186/s41065-025-00491-8
- TIMP1 promotes microglia M2 polarization through MAPK pathway to ameliorate early brain injury after ischemia.Journal: HereditasIn common: stroke, rat, cellular / molecular, 1 reference
- [7] doi:10.1111/cns.70399
- S-Propargyl-Cysteine Attenuates Stroke Heterogeneity via Promoting Protective Autophagy Across Multiple Neural Cell Types: Insights From Single-Cell Sequencing.Journal: CNS neuroscience & therapeuticsIn common: stroke, rat, cellular / molecular, 1 reference
- [8] doi:10.3390/biology14060589
- &
lt;i& gt;Periplaneta americana& lt;/ i& gt; (L.) Extract PAS840 Promotes Ischemic Stroke Recovery by Inhibiting Inflammasome Activation. Journal: BiologyIn common: stroke, rat, cellular / molecular, 1 reference - [9] doi:10.1016/j.isci.2025.112552
- Young rat vascular endothelial cells promote neurological recovery of stroke aged rat via HIF-1α.Journal: iScienceIn common: stroke, rat, cellular / molecular, 1 reference
- [10] doi:10.1073/pnas.2425494122
- Design and structural basis of selective 1,4-dihydropyridine inhibitors of the calcium-activated potassium channel K&
lt;sub& gt;Ca& lt;/ sub& gt;3.1. Journal: Proceedings of the National Academy of Sciences of the United States of AmericaIn common: stroke, rat, cellular / molecular, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
